SET-M33

N/A

Report date: 2026/01/29 16:01:18
NME

Base Information

Drug NameSET-M33
Drug Alias NameSET-M33
ClassificationSmall molecules > Heterocyclic drugs > AntibioticsSmall molecules > Synthetic peptide
Mechanisms of ActionLipopolysaccharide (LPS) modulators
TargetsLipopolysaccharide (LPS)
Therapy Area/IndicationsGram-Negative Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesErasmus University Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesErasmus University Medical Center
Inactive CompaniesN/A
Active IndicationsGram-Negative Bacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A